Chinese and Western medicine therapy on chronic heart failure patients on quality of life.docVIP

Chinese and Western medicine therapy on chronic heart failure patients on quality of life.doc

  1. 1、本文档共7页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
 PAGE \* MERGEFORMAT 7 Chinese and Western medicine therapy on chronic heart failure patients on quality of life [Keywords:] Chronic heart failure, Chinese and Western medicine, quality of life Chronic heart failure (CHF) is a traditional Chinese medicine, “palpitations”, “Chest”, “asthma card”, “edema” and other areas, the cause is common in coronary heart disease, pulmonary heart disease, hypertensive heart disease, cardiomyopathy, etc. mainly as palpitations, chest tightness or chest pain, dyspnea, lower extremity edema, cyanosis, etc. A lip seriously affect the quality of life of patients. I used Integrative Medicine CHF, can significantly improve the life quality of patients, the results reported below. 1 Materials and Methods 1.1 General Information Randomly divided into 2 groups: treatment group of 50 patients, 29 males and 21 females, mean age (58.42 + -8.56 years) in the control group of 50 patients, 26 males and 24 females, mean age (61.19 + -9.24) .2-year-old group sex, age, etiology of heart failure after statistical processing, the difference was not significant (Pgt; 0.05), comparable. 1.2 Diagnostic criteria Meet the diagnostic criteria of chronic heart failure [1], in line with New York Heart Association functional class (NYHA) Ⅱ ~ Ⅲ grade, remove the liver, kidney disease caused by chronic heart failure. 1.3 Treatment Control group: use of digitalis, diuretics, nitrates and angiotensin converting enzyme inhibitor therapy, if necessary, oxygen, and be low-salt diet and bed rest. The treatment group: In the above treatment, while giving CSI solution (Southern laboratories, Yaan Sanjiu Pharmaceutical Co) 30 mL, 5% glucose injection 100 ~ 250 mL of intravenous infusion, day 1 .2 groups were 15 d as a course of treatment. 1.4 OUTCOME MEASURES Clinical efficacy ①, ② to determine cardiac function, ③ labor endurance, ④ quality of life. 1.5 Clinical Standards Clinical efficacy of standard 1.5.1 With reference to

文档评论(0)

hhuiws1482 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:5024214302000003

1亿VIP精品文档

相关文档